Subsequent neoplasia in chronic lymphocytic leukemia

D. Manusow and B. H. Weinerman

We performed a retrospective analysis of all 102 cases of chronic lymphocytic leukemia (CLL) treated by the Hematology Service of the University of Manitoba from Jan 1, 1955, to April 1, 1974. The incidence of secondary cancer was compared with that in the Cancer Registry population of Manitoba of the same age and sex distribution. The risk of all cancers developing in patients with CLL was threefold that for the age- and sex-matched population, eightfold for skin cancers, and twofold for all cancers excluding skin cancer.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification
Volkheimer et al.
Blood 2007;109:1559-1567.
ABSTRACT | FULL TEXT  

Effect of Rapamycin on Mouse Chronic Lymphocytic Leukemia and the Development of Nonhematopoietic Malignancies in E{micro}-TCL1 Transgenic Mice
Zanesi et al.
Cancer Res. 2006;66:915-920.
ABSTRACT | FULL TEXT  

High Recurrence Rates of Basal Cell Carcinoma After Mohs Surgery in Patients With Chronic Lymphocytic Leukemia
Mehrany et al.
Arch Dermatol 2004;140:985-988.
ABSTRACT | FULL TEXT  

Immunosuppression and Skin Cancer: Pathogenetic Insights, Therapeutic Challenges, and Opportunities for Innovation
Otley
Arch Dermatol 2002;138:827-828.
FULL TEXT  

Solid tumors after chronic lymphocytic leukemia
Hisada et al.
Blood 2001;98:1979-1981.
ABSTRACT | FULL TEXT  

Second Malignancies as a Consequence of Nucleoside Analog Therapy for Chronic Lymphoid Leukemias
Cheson et al.
JCO 1999;17:2454-2454.
ABSTRACT | FULL TEXT